Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genetic Tech Spn ADR (NQ: GENE )

2.390 +0.020 (+0.84%)
Streaming Delayed Price Updated: 3:58 PM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Genetic Tech Spn ADR

< Previous 1 2 Next >
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Announces $2 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
GTG to pilot GeneType in Breast Screen centers across the U.S.
From Genetic Technologies Ltd
Via GlobeNewswire
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
From Genetic Technologies Ltd
Via GlobeNewswire
GTG Global Collaborations and Innovation Update
From Genetic Technologies Ltd
Via GlobeNewswire
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
From Genetic Technologies Ltd
Via GlobeNewswire
GTG to launch U.S. Customer Digital Media Sales Campaign
From Genetic Technologies Ltd
Via GlobeNewswire
Launching our most comprehensive test and expanding into new global markets
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
Via ACCESSWIRE
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
From Genetic Technologies Ltd
Via GlobeNewswire
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
From Genetic Technologies Ltd
Via GlobeNewswire
Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
Via ACCESSWIRE
Genetic Technologies building pathway to profitability
Genetic Technologies Ltd (ASX:GTG; NASDAQ:GENE) CEO Simon Morriss tells Proactive the focus over the next 18 years is putting the pathway in place to see the business on track to profitability. GTG... 
Via TheNewswire.com
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
From Genetic Technologies Ltd
Via GlobeNewswire
Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report® on Bloomberg TV
Via ACCESSWIRE
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
From Genetic Technologies Ltd
Via GlobeNewswire
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice 
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
Via ACCESSWIRE
Annual Results – Momentum Building on our Commercial Plans
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Limited Announces Updated Investor Presentation
From Genetic Technologies Ltd
Via GlobeNewswire
Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
From Genetic Technologies Ltd
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.